You know, two of the small pharmas that received BTD finished financings VERY shortly before announcing their BTD. Syndax was one and Scioderm was the other and both fundraisings were completed something like a week before announcement. The company's claim one happened prior to the other but I seriously doubt that, especially when the company would have known an answer would be given in 60 days. I think it might have been an unwritten rule or one of those "contingencies" surrounding BTD that the FDA would be a lot more relaxed if the company had a year's worth of cash on hand. All IMO.